Etretinate therapy and immune reactivity.
D005050:Etretinate / Q000378:metabolism / Q000494:pharmacology*; D006207:Half-Life; D006801:Humans; D007642:Keratosis / Q000188:drug therapy / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008934:Mitogens / Q000494:pharmacology
D008934:Mitogens; D005050:Etretinate